Bioactivity Evaluation of a Novel Formulated Curcumin

Area of Science:

• Pharmacology
• Biotechnology
• Cancer Research

Background:

• Curcumin, a compound with known anticancer properties, suffers from poor oral bioavailability, limiting its therapeutic applications.
• Traditional use highlights curcumin's health benefits, but formulation challenges hinder its widespread adoption as a supplement or medical food.

Purpose of the Study:

• To formulate curcumin pellets using solid dispersion to enhance oral bioavailability.
• To investigate the biological functions and cellular mechanisms of the formulated curcumin using big data analysis.
• To compare the efficacy and mechanisms of formulated curcumin with conventional curcumin.

Main Methods:

• Curcumin pellets were prepared using a solid dispersion technique.
• The C-Map and LINCS Unified Environment (CLUE) database was utilized for gene expression analysis.
• ConsensusPathDB was employed for pathway and target prediction.
• Biochemical assays were performed to assess apoptosis induction in hepatocellular carcinoma (HCC) cell lines.

Main Results:

• The formulated curcumin pellets exhibited reduced particle size, increased water solubility, and improved porosity.
• Formulated curcumin demonstrated enhanced oral bioavailability in animal models.
• Gene expression analysis indicated that formulated curcumin inhibits the NF-κB pathway, similar to conventional curcumin.
• Both formulated and conventional curcumin induced apoptosis in HCC cell lines, suggesting similar biological functions.

Conclusions:

• Curcumin pellet formulation via solid dispersion effectively enhances oral bioavailability while preserving cellular anticancer mechanisms.
• Big data analysis confirmed conserved biological functions and predicted novel mechanisms for the formulated curcumin.
• This formulation represents a promising strategy for developing more effective curcumin-based nutraceuticals and therapeutics.